Neopolydex

19 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1580.0%

Death Rate

Active Ingredients

Neopolydex

Administration Routes

OphthalmicUnknownTopicalIntraocular

Species Affected

Dog 18

Cat 1

Most Affected Breeds

Shih Tzu 2

Crossbred Canine/dog 2

Schnauzer (unspecified) 2

Maltese 2

Terrier - Yorkshire 1

Schnauzer - Miniature 1

Beagle 1

Pug 1

Terrier - Cairn 1

Havanese 1

Most Reported Reactions

Vomiting 5

Seizure NOS 4

Death by euthanasia 2

Decreased appetite 2

Elevated alanine aminotransferase (ALT) 2

Lethargy (see also Central nervous system depression in 'Neurological') 2

Diarrhoea 2

Lack of efficacy - NOS 2

Circling - neurological disorder (see also 'Behavioural disorders') 1

Nystagmus 1

Overdose 1

Hyperpigmentation 1

Outcome Breakdown

Recovered/Normal

7 (36.8%)

Ongoing

7 (36.8%)

Euthanized

2 (10.5%)

Outcome Unknown

2 (10.5%)

Died

1 (5.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.